Literature DB >> 27113574

Synthesis of a peptide-universal nucleotide antigen: towards next-generation antibodies to detect topoisomerase I-DNA covalent complexes.

Angela L Perkins1, Kevin L Peterson2, Thomas G Beito3, Karen S Flatten2, Scott H Kaufmann2, Daniel A Harki1.   

Abstract

The topoisomerase (topo) I-DNA covalent complex represents an attractive target for developing diagnostic antibodies to measure responsiveness to drugs. We report a new antigen, peptide , and four murine monoclonal antibodies raised against that exhibit excellent specificity for recognition of in comparison to structurally similar peptides by enzyme-linked immunosorbent assays. Although topo I-DNA complex detection was not achieved in cellular samples by these new antibodies, a new strategy for antigen design is reported.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27113574      PMCID: PMC4922793          DOI: 10.1039/c5ob02049b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  40 in total

Review 1.  DNA topoisomerases: structure, function, and mechanism.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

2.  The mechanism of topoisomerase I poisoning by a camptothecin analog.

Authors:  Bart L Staker; Kathryn Hjerrild; Michael D Feese; Craig A Behnke; Alex B Burgin; Lance Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-08       Impact factor: 11.205

3.  A protease pathway for the repair of topoisomerase II-DNA covalent complexes.

Authors:  Ailing Zhang; Yi Lisa Lyu; Chao-Po Lin; Nai Zhou; Anna M Azarova; Laurence M Wood; Leroy F Liu
Journal:  J Biol Chem       Date:  2006-09-13       Impact factor: 5.157

4.  Efficient synthesis and applications of peptides containing adenylylated tyrosine residues.

Authors:  Cornelis Smit; Julia Blümer; Martijn F Eerland; Michael F Albers; Matthias P Müller; Roger S Goody; Aymelt Itzen; Christian Hedberg
Journal:  Angew Chem Int Ed Engl       Date:  2011-08-25       Impact factor: 15.336

5.  Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity.

Authors:  P Fiorani; J F Amatruda; A Silvestri; R H Butler; M A Bjornsti; P Benedetti
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

Review 6.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

Review 7.  Molecular perspectives on protein adenylylation.

Authors:  Christian Hedberg; Aymelt Itzen
Journal:  ACS Chem Biol       Date:  2014-12-17       Impact factor: 5.100

8.  Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial.

Authors:  Michael S Braun; Susan D Richman; Philip Quirke; Catherine Daly; Julian W Adlard; Faye Elliott; Jennifer H Barrett; Peter Selby; Angela M Meade; Richard J Stephens; Mahesh K B Parmar; Matthew T Seymour
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

9.  Immunodetection of human topoisomerase I-DNA covalent complexes.

Authors:  Anand G Patel; Karen S Flatten; Kevin L Peterson; Thomas G Beito; Paula A Schneider; Angela L Perkins; Daniel A Harki; Scott H Kaufmann
Journal:  Nucleic Acids Res       Date:  2016-02-24       Impact factor: 16.971

10.  beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin.

Authors:  C J Li; L Averboukh; A B Pardee
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.486

View more
  1 in total

1.  Reassessing APOBEC3G Inhibition by HIV-1 Vif-Derived Peptides.

Authors:  Christopher M Richards; Ming Li; Angela L Perkins; Anurag Rathore; Daniel A Harki; Reuben S Harris
Journal:  J Mol Biol       Date:  2016-11-22       Impact factor: 5.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.